By Gina Shaw
Rapid nasal polymerase chain reaction (PCR) testing for methicillin-resistant Staphylococcus aureus (MRSA) significantly reduced inpatient vancomycin use and led to notable cost savings, reported investigators from Montefiore Medical Center (MMC) and Albert Einstein College of Medicine in a presentation at the 2022 annual MAD-ID (Making a Difference in Infectious Diseases) conference, in Orlando, Fla.
“Empiric IV vancomycin prescribing to provide MRSA coverage confers risk for